|

AUCD Community Inclusion

AUCD’s Community Inclusion Team supports the University Centers for Excellence in Developmental Disabilities (UCEDD) Network in partnership with the Administration for Community Living.

Learn More
|

AUCD Maternal and Child Health Engagement

AUCD’s Maternal and Child Health Engagement supports the Autism CARES Programs, including LEND and DBP Programs.

Learn More
|

AUCD Public Health

AUCD’s Public Health Team works to create health promotion and public health efforts that include people with disabilities.

Learn More
|

AUCD Emerging Leaders Community

AUCD Emerging Leaders are a part of a community that includes trainees, early career professionals, self-advocates, and family members from AUCD member Centers and Programs.

Learn More

Donate

Project

PHARM - 52-week, open-label study of the safety and tolerability of Aripiprazole in the treatment of children and adolescents with autistic disorder

Center:

OH-The Nisonger Center, UCEDD/LEND

Fiscal Year:

2008

Contact Information:

Ashley Reno
[email protected]
614-688-8214

Project Description:

The purpose of this study is to look at the safety and tolerability of different doses of aripiprazole. The different doses will be studied in children and adolescents 6 to 17 years of age who have been diagnosed with serious behavioral problems related to autism.

Keyword(s):

Autism, Irritability, Aggression, Clincial Trial

Core Function(s):

Performing Research or Evaluation

Area of Emphasis

Health-Related Activities

Target Audience:

Children/Adolescents with Disabilities/SHCN

Unserved or Under-served Populations:

Other

Primary Target Audience Geographic Descriptor:

National